Archive for May, 2009
How do you get started when you are going into a field of cardiology?
Monday, May 25th, 2009♥мαи∂ιѕ♥ asked:
I’m starting college Fall of 2008 (Basically i start Jan. 2009) and I’m going in for being a Nursing Assistant, but planning on taking a class on cardiology (since this my my NOW major).
I’m starting college Fall of 2008 (Basically i start Jan. 2009) and I’m going in for being a Nursing Assistant, but planning on taking a class on cardiology (since this my my NOW major).
How do you get started in this field? (Cardiology)
Carl
What are some interesting and fascinating facts about cardiologists/cardiology?
Thursday, May 21st, 2009What Is Fibromyalgia/ Chronic Fatigue Syndrome? Treatment Intervention: A New Model Part 3
Thursday, May 21st, 2009Dr. Mark J Shaw asked:
How does the lymphatic exercise protocol help to reduce toxicity?
Manual stimulation of the lymphatic system in the head, neck and chest cavity, specific to reducing neurotoxicity means that the first areas to benefit directly from the reduction in toxicity are the blood ventricle system around the brain.
This will seriously limit the damage potential to the brain and improve your overall long term prognosis.
Gentle mobilization and treatment of the thoracic chest cavity around T7 will create rapid detox. A period of serious adjustment will take place while this happens. The supplement and diet regimes I now use complement this process to aid the detox while it is actually happening.
A powerful cocktail of antioxidants, specific vitamins and minerals, essential enzymes, digestive support, fatty acids and other elements are used to mop up the released toxins, restore essential ingredients and reverse the downward spiral.
Metabolic Cardiology and Mitochondrial Recovery:
How can diet and supplements help to reduce toxicity and complement my Fibromyalgia and Chronic Fatigue protocols?
I am now of the firm belief that diet plays a hugely important role in the cycle and development of these conditions and I will outline precisely what has lead me to this assertion.
Across the hundreds of patients that I have seen, a small proportion had similar pre-illness situations that I could not explain. They did not fit into the models I was using.
While I was trying to get to the cause of their toxic stress as part of my initial investigations it would become apparent that they had no exposure to what I consider to be the normal toxins that I see on a daily basis that cause the majority of these morbid conditions.
They also reported that they could not detail a specific date or illness that they considered to be the “onset” or “trigger” infection as I like to call it.
Also and most disturbingly they did not respond beyond a certain degree to my protocol. They would reach a plateau at around 50% improvement and remain stuck there.
However their symptoms as described by my other diagnostics and CDC requirements were exactly those of Fibromyalgia/CFS.
I began to look deeper at all feasible etiology, and found that diet was the only common link, all these people were addicted to one or all of three key products which appeared to be at the source of their “malignant toxicity”:
1/ Wheat based carbohydrates particularly gluten.
2/ Dairy products and/or
3/ Yeast based drinks and other products.
Looking through the literature I decided to press on and referred them for blood based intolerance tests.
The results were conclusive. All these patients had strong intolerance reactions to the products mentioned above and I decided to try them on what I describe as a “primal low glycaemic” diet.
Within four weeks all these patients began to show rapid improvements above the 50% marker in conjunction with the other elements of my Fibromyalgia and Chronic Fatigue protocols.
Further investigations revealed that the foods they were eating were in fact not digesting well, and were causing allergic reactions which would then produce antigenic molecules (toxic molecules) which created their own toxic stress conditions.
So basically simply by eating what we consider in our basic Western diet to be healthy high availability foods containing wheat, dairy and yeast these particular individuals digestive and immune systems were generating toxic molecules in their own blood.
I went back to the literature and it became clear that the evidence is stacking up strongly against these products which form an enormous section of our modern Western diets.
Looking around my local food store it became clear that almost every single product, in particular anything that cannot be described as a natural or organic food, contained wheat, dairy, albumen (egg white) and yeast, the four products that generate the strongest immune reactions in human beings (as described by the largest food intolerance testing companies in the US and Europe)
This conundrum baffled me for several weeks and lead me further into the paperchase. Here are a couple of interesting examples.
In Japan, Thailand and China, 90% of the indigenous populations lack the enzyme necessary to digest dairy produce. It appears in the west we have evolved a specific enzyme, lactase in response to the amount of dairy produce we consume. Could it be that we are NOT meant to consume a product meant for young calves who need to grow at a colossal rate in order to avoid being eaten by prey?
The Eskimos had absolute zero incidence of heart disease or cancer until the 1940’s when they adopted western diets containing wheat and dairy.
Almost 15% of all populations may be intolerant to a complex protein molecule, gluten, which is very difficult to break down and is found in wheat and to a lesser extent in other grains.
Long term consumption of these foods appeared to be affecting the digestive system of these patients and was creating situations where there was increased permeability of the gut wall, thereby allowing partially digested food to enter the blood stream.
The dietary investigations lead me deep into the world of metabolic cardiology and the dreadful effects of mitochondrial failure.
My regime for the primal diet and mitochondrial supplements was developed alongside the lymphatic musculoskeletal protocol.
The benefits to the patient from combining the two protocols is that they work symbiotically to create an even deeper, more rapid healing effect with an even higher success rate.
So high is the success rate that the flowchart was developed to give a diagnostic intervention-based model to the medical profession for the very first time.
Stopping smoking as i have detailed previously has always been a core of my treatment recommendations since the beginning and refusing treatment to people clearly addicted to the most addictive substance on earth has always left me feeling disappointed.
Working with Joseph Davies, an expert in neuro-linguistic programming and self hypnosis has been a great revelation and has enabled us to overcome this previous drawback.
Kevin
How does the lymphatic exercise protocol help to reduce toxicity?
Manual stimulation of the lymphatic system in the head, neck and chest cavity, specific to reducing neurotoxicity means that the first areas to benefit directly from the reduction in toxicity are the blood ventricle system around the brain.
This will seriously limit the damage potential to the brain and improve your overall long term prognosis.
Gentle mobilization and treatment of the thoracic chest cavity around T7 will create rapid detox. A period of serious adjustment will take place while this happens. The supplement and diet regimes I now use complement this process to aid the detox while it is actually happening.
A powerful cocktail of antioxidants, specific vitamins and minerals, essential enzymes, digestive support, fatty acids and other elements are used to mop up the released toxins, restore essential ingredients and reverse the downward spiral.
Metabolic Cardiology and Mitochondrial Recovery:
How can diet and supplements help to reduce toxicity and complement my Fibromyalgia and Chronic Fatigue protocols?
I am now of the firm belief that diet plays a hugely important role in the cycle and development of these conditions and I will outline precisely what has lead me to this assertion.
Across the hundreds of patients that I have seen, a small proportion had similar pre-illness situations that I could not explain. They did not fit into the models I was using.
While I was trying to get to the cause of their toxic stress as part of my initial investigations it would become apparent that they had no exposure to what I consider to be the normal toxins that I see on a daily basis that cause the majority of these morbid conditions.
They also reported that they could not detail a specific date or illness that they considered to be the “onset” or “trigger” infection as I like to call it.
Also and most disturbingly they did not respond beyond a certain degree to my protocol. They would reach a plateau at around 50% improvement and remain stuck there.
However their symptoms as described by my other diagnostics and CDC requirements were exactly those of Fibromyalgia/CFS.
I began to look deeper at all feasible etiology, and found that diet was the only common link, all these people were addicted to one or all of three key products which appeared to be at the source of their “malignant toxicity”:
1/ Wheat based carbohydrates particularly gluten.
2/ Dairy products and/or
3/ Yeast based drinks and other products.
Looking through the literature I decided to press on and referred them for blood based intolerance tests.
The results were conclusive. All these patients had strong intolerance reactions to the products mentioned above and I decided to try them on what I describe as a “primal low glycaemic” diet.
Within four weeks all these patients began to show rapid improvements above the 50% marker in conjunction with the other elements of my Fibromyalgia and Chronic Fatigue protocols.
Further investigations revealed that the foods they were eating were in fact not digesting well, and were causing allergic reactions which would then produce antigenic molecules (toxic molecules) which created their own toxic stress conditions.
So basically simply by eating what we consider in our basic Western diet to be healthy high availability foods containing wheat, dairy and yeast these particular individuals digestive and immune systems were generating toxic molecules in their own blood.
I went back to the literature and it became clear that the evidence is stacking up strongly against these products which form an enormous section of our modern Western diets.
Looking around my local food store it became clear that almost every single product, in particular anything that cannot be described as a natural or organic food, contained wheat, dairy, albumen (egg white) and yeast, the four products that generate the strongest immune reactions in human beings (as described by the largest food intolerance testing companies in the US and Europe)
This conundrum baffled me for several weeks and lead me further into the paperchase. Here are a couple of interesting examples.
In Japan, Thailand and China, 90% of the indigenous populations lack the enzyme necessary to digest dairy produce. It appears in the west we have evolved a specific enzyme, lactase in response to the amount of dairy produce we consume. Could it be that we are NOT meant to consume a product meant for young calves who need to grow at a colossal rate in order to avoid being eaten by prey?
The Eskimos had absolute zero incidence of heart disease or cancer until the 1940’s when they adopted western diets containing wheat and dairy.
Almost 15% of all populations may be intolerant to a complex protein molecule, gluten, which is very difficult to break down and is found in wheat and to a lesser extent in other grains.
Long term consumption of these foods appeared to be affecting the digestive system of these patients and was creating situations where there was increased permeability of the gut wall, thereby allowing partially digested food to enter the blood stream.
The dietary investigations lead me deep into the world of metabolic cardiology and the dreadful effects of mitochondrial failure.
My regime for the primal diet and mitochondrial supplements was developed alongside the lymphatic musculoskeletal protocol.
The benefits to the patient from combining the two protocols is that they work symbiotically to create an even deeper, more rapid healing effect with an even higher success rate.
So high is the success rate that the flowchart was developed to give a diagnostic intervention-based model to the medical profession for the very first time.
Stopping smoking as i have detailed previously has always been a core of my treatment recommendations since the beginning and refusing treatment to people clearly addicted to the most addictive substance on earth has always left me feeling disappointed.
Working with Joseph Davies, an expert in neuro-linguistic programming and self hypnosis has been a great revelation and has enabled us to overcome this previous drawback.
Kevin
how can I trvel to Germany , to spescialize in cardiology ?
Wednesday, May 13th, 2009zigo asked:
Dear madam/sir:
I have graduated since 2002 ,faculty of medicine ,damascus university ,and have three years expirience in internal medicine ,so I want to continou in cardiolog field in Germany.
nowadays I am woking in Saudi Arabia as internal medical resident .
I ‘ll be so lucky if I have a chance of job in the mentioned branch of medicine .
with my best regards to you for your help.
Dr Takosheen Habsh (kurish man from syria)
thank you.
Mario
Dear madam/sir:
I have graduated since 2002 ,faculty of medicine ,damascus university ,and have three years expirience in internal medicine ,so I want to continou in cardiolog field in Germany.
nowadays I am woking in Saudi Arabia as internal medical resident .
I ‘ll be so lucky if I have a chance of job in the mentioned branch of medicine .
with my best regards to you for your help.
Dr Takosheen Habsh (kurish man from syria)
thank you.
Mario
Omega-3 Fats From Fish Reduce the Risk of Repeat Heart Attacks by as Much as 45%
Tuesday, May 12th, 2009Emilia Klapp, R.D., B.S. asked:
Introduction
Interest in the Mediterranean diet with its high content of Omega-3 fatty acids from fish has skyrocketed in recent years, after it has been observed that people living in regions bordering the Mediterranean Sea appeared to live longer and suffer less from cardiovascular disease. In particular, a Mediterranean diet that includes fish has long been associated with a low rate of heart disease in countries such as Spain, Greece, and Italy.
But whether or not this diet can benefit patients who have already suffered a heart attack has not been tested in depth before the GISSI study. Thus, the purpose of GISSI was to investigate the effects of omega-3 fatty acids and vitamin E on cardiovascular events after people have had a heart attack.
Who forms the GISSI study group?
GISSI, an Italian group for the study of the survival of Heart Attacks (Myocardial Infarction) is an influential cardiology research group founded as a collaboration between two Italian organisations – the Mario Negri Institute and the Associazione Nazionale dei Medici Cardiologi Ospedalieri (ANMCO). The trials carried out by GISSI have obtained wide recognition in the international world of cardiology and are considered a methodological landmark. Four large-scale clinical trials over the past 20 years (GISSI 1, GISSI 2, GISSI 3, GISSI Prevention) have involved more than 60,000 patients with acute myocardial infarction.
The GISSI study
Between October 1993 to September 1995, 11,324 patients participated in the GISSI trial. To qualify as a participant for the study, the patients must have survived a recent heart attack (less than three months prior to being enrolled in the study). Patients were randomly assigned to four treatment groups:
Group 1- Patients received 1 gram of fish oil containing 85% of Eicosapentaenoic acid, EPA, and Docosahexaenoic acid, DHA.
Group 2- Patients received 300 mg of vitamin E, a synthetic a-tocopherol supplement.
Group 3- Patients received a combination of omega-3 and vitamin E
Group 4- Control group, patients did not receive treatment
The results were very significant for dietary supplementation with omega-3s from fish oil. Treatment with omega-3s resulted in a 45% reduction in the risk of having a sudden fatal heart attack, a 30% decrease from cardiovascular mortality and a 20% reduction in overall mortality. According to the researchers, Vitamin E supplements were found to have no benefits on heart attacks.
Marchioli, senior author of the study, reported that the people who followed a Mediterranean style diet that included more vegetables, fruit, fish, but little butter, were less likely to die than people who reported eating higher amounts of butter, cheese, and vegetable oils other than olive oil.
Similar benefits of a Mediterranean-style diet were seen in earlier, smaller randomized trials. In the Lyon Diet Heart Study, benefits were seen in patients who after a heart attack were assigned to a diet rich in [alpha]-linoleic acid, ALA, from plant sources along with plenty of legumes, cereals, fresh fruits, and vegetables. Compared with those assigned to a “prudent” diet similar to the American Heart Association step 1 diet, those on the Mediterranean style diet had a 70% reduction in deaths, repeat heart attacks, unstable angina, stroke, congestive heart failure, or embolic events.
Where do you find EPA and DHA?
Long-chain omega-3s, EPA and DHA, are most abundant in fish and shellfish, particularly fatty fish such as salmon, rainbow trout, tuna, mackerel, herring, and sardines. All seafood has some EPA and DHA. Fish oil capsules are a rich source of EPA and DHA, too.
How much Omega-3s do you need to take?
100 grams (3.5 ounces) of salmon provide 5,000 mg of EPA and DHA, followed by tuna with about 2,300 mg and trout with 1,470 mg. Other fish with high content of Omega-3s are sardines, mackerel, and anchovies.
A daily ingest should contribute between 1.1 and 1.4 grams. A fatty fish portion will cover this need.
For people who already have a heart condition, eating seafood more often, or consuming marine omega-3s from supplements, is just as important. If you have already suffered a heart attack, you could supplement your fish intake with a good quality fish oil supplement.
Are Plant and Fish Omega-3s born equal?
No. The omega -3s found in terrestrial plants, such as some nuts or the ones found in enriched foods, are ALA. Terrestrial plants have only ALA . This omega-3 has some, but not all, of the health benefits associated with fish oil omega-3s. It can also be converted in the body to EPA and very small amounts of DHA but humans perform this conversion very poorly, less than 5%, so relying only on ALA for all omega-3s risks having a deficiency in EPA and especially in DHA
And remember that…
Our body either cannot produce Omega-3s or does not produce enough quantities to support good health. Therefore, they have to be ingested from our diet.
Francisco
Introduction
Interest in the Mediterranean diet with its high content of Omega-3 fatty acids from fish has skyrocketed in recent years, after it has been observed that people living in regions bordering the Mediterranean Sea appeared to live longer and suffer less from cardiovascular disease. In particular, a Mediterranean diet that includes fish has long been associated with a low rate of heart disease in countries such as Spain, Greece, and Italy.
But whether or not this diet can benefit patients who have already suffered a heart attack has not been tested in depth before the GISSI study. Thus, the purpose of GISSI was to investigate the effects of omega-3 fatty acids and vitamin E on cardiovascular events after people have had a heart attack.
Who forms the GISSI study group?
GISSI, an Italian group for the study of the survival of Heart Attacks (Myocardial Infarction) is an influential cardiology research group founded as a collaboration between two Italian organisations – the Mario Negri Institute and the Associazione Nazionale dei Medici Cardiologi Ospedalieri (ANMCO). The trials carried out by GISSI have obtained wide recognition in the international world of cardiology and are considered a methodological landmark. Four large-scale clinical trials over the past 20 years (GISSI 1, GISSI 2, GISSI 3, GISSI Prevention) have involved more than 60,000 patients with acute myocardial infarction.
The GISSI study
Between October 1993 to September 1995, 11,324 patients participated in the GISSI trial. To qualify as a participant for the study, the patients must have survived a recent heart attack (less than three months prior to being enrolled in the study). Patients were randomly assigned to four treatment groups:
Group 1- Patients received 1 gram of fish oil containing 85% of Eicosapentaenoic acid, EPA, and Docosahexaenoic acid, DHA.
Group 2- Patients received 300 mg of vitamin E, a synthetic a-tocopherol supplement.
Group 3- Patients received a combination of omega-3 and vitamin E
Group 4- Control group, patients did not receive treatment
The results were very significant for dietary supplementation with omega-3s from fish oil. Treatment with omega-3s resulted in a 45% reduction in the risk of having a sudden fatal heart attack, a 30% decrease from cardiovascular mortality and a 20% reduction in overall mortality. According to the researchers, Vitamin E supplements were found to have no benefits on heart attacks.
Marchioli, senior author of the study, reported that the people who followed a Mediterranean style diet that included more vegetables, fruit, fish, but little butter, were less likely to die than people who reported eating higher amounts of butter, cheese, and vegetable oils other than olive oil.
Similar benefits of a Mediterranean-style diet were seen in earlier, smaller randomized trials. In the Lyon Diet Heart Study, benefits were seen in patients who after a heart attack were assigned to a diet rich in [alpha]-linoleic acid, ALA, from plant sources along with plenty of legumes, cereals, fresh fruits, and vegetables. Compared with those assigned to a “prudent” diet similar to the American Heart Association step 1 diet, those on the Mediterranean style diet had a 70% reduction in deaths, repeat heart attacks, unstable angina, stroke, congestive heart failure, or embolic events.
Where do you find EPA and DHA?
Long-chain omega-3s, EPA and DHA, are most abundant in fish and shellfish, particularly fatty fish such as salmon, rainbow trout, tuna, mackerel, herring, and sardines. All seafood has some EPA and DHA. Fish oil capsules are a rich source of EPA and DHA, too.
How much Omega-3s do you need to take?
100 grams (3.5 ounces) of salmon provide 5,000 mg of EPA and DHA, followed by tuna with about 2,300 mg and trout with 1,470 mg. Other fish with high content of Omega-3s are sardines, mackerel, and anchovies.
A daily ingest should contribute between 1.1 and 1.4 grams. A fatty fish portion will cover this need.
For people who already have a heart condition, eating seafood more often, or consuming marine omega-3s from supplements, is just as important. If you have already suffered a heart attack, you could supplement your fish intake with a good quality fish oil supplement.
Are Plant and Fish Omega-3s born equal?
No. The omega -3s found in terrestrial plants, such as some nuts or the ones found in enriched foods, are ALA. Terrestrial plants have only ALA . This omega-3 has some, but not all, of the health benefits associated with fish oil omega-3s. It can also be converted in the body to EPA and very small amounts of DHA but humans perform this conversion very poorly, less than 5%, so relying only on ALA for all omega-3s risks having a deficiency in EPA and especially in DHA
And remember that…
Our body either cannot produce Omega-3s or does not produce enough quantities to support good health. Therefore, they have to be ingested from our diet.
Francisco
India Cardiovascular Devices Medical Equipment Market Report
Thursday, May 7th, 2009Bharat Book Bureau asked:
This report is an essential source for key data relating to the India Cardiovascular Devices medical equipment market. The report offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information.
Scope of the Report
• This report provides detailed data on market size by volume and value.
• It gives key company share information for leading competitors in the market.
• Breaks down revenues by distribution channel.
• Provides forecasts of market values.
• All figures are based on rigorous research methodologies including in-depth primary and secondary research.
• Obtain the most up to date medical equipment market information available.
• Support sales activities by understanding your customers’ businesses better.
• Identify key growth market categories and segments.
• Develop your strategies on the basis of forecast market growth.
Table of Contents
CHAPTER 1 TABLE OF CONTENTS 2
1.01 List of tables 3
1.02 List of figures 5
CHAPTER 2 INTRODUCTION 6
2.01 What Is This Report About? 6
2.02 Market Definitions 6
Cardiovascular Devices 6
Interventional Cardiology 6
Peripheral Vascular Devices 6
Cardiac Rhythm Management 6
Cardiovascular Surgery 6
Cardiovascular Prosthetic Devices 7
Cardiovascular Monitoring and Diagnostic Devices 7
CHAPTER 3 CARDIOVASCULAR DEVICES OVERALL REVENUES 8
CHAPTER 4 CARDIOVASCULAR DEVICES CATEGORY REVENUES 11
CHAPTER 5 CARDIOVASCULAR DEVICES CATEGORY VOLUMES 15
CHAPTER 6 CARDIOVASCULAR DEVICES DISTRIBUTION SHARE 17
CHAPTER 7 CARDIOVASCULAR DEVICES COMPANY SHARE 22
CHAPTER 8 APPENDIX 29
8.01 Methodology 29
8.02 Currency Conversion 30
8.03 Contact Us 31
8.04 Disclaimer 31
List of Tables
Table 1: Cardiovascular Devices in India, Overall Revenues ($ mn), 2000-2011 8
Table 2: Cardiovascular Devices in India, Overall Revenues ($ mn), Historic, 2000-2006 9
Table 3: Cardiovascular Devices in India, Overall Revenues ($ mn), Forecast, 2006-2011 10
Table 4: Cardiovascular Devices in India, Category Revenues ($ mn), 2000-2011 12
Table 5: Cardiovascular Devices in India, Category Revenues ($ mn), Historic, 2000-2006 13
Table 6: Cardiovascular Devices in India, Category Revenues ($ mn), Forecast, 2006-2011 14
Table 7: Cardiovascular Devices in India, Category Volume (Units), 2000-2011 15
Table 8: Cardiovascular Devices in India, Category Volume (Units), Historic, 2000-2006 15
Table 9: Cardiovascular Devices in India, Category Volume (Units), Forecast, 2006-2011 16
Table 10: Cardiovascular Devices, Interventional Cardiology in India, Distribution by Revenue ($ mn), 2005-2006 17
Table 11: Cardiovascular Devices, Peripheral Vascular Devices in India, Distribution by Revenue ($ mn), 2005-2006 18
Table 12: Cardiovascular Devices, Cardiac Rhythm Management in India, Distribution by Revenue ($ mn), 2005-2006 19
Table 13: Cardiovascular Devices, Cardiovascular Surgery in India, Distribution by Revenue ($ mn), 2005-2006 19
Table 14: Cardiovascular Devices, Cardiovascular Prosthetic Devices in India, Distribution by Revenue ($ mn), 2005-2006 20
Table 15: Cardiovascular Devices, Cardiovascular Monitoring and Diagnostic Devices in India, Distribution by Revenue ($ mn), 2005-2006 21
Table 16: Cardiovascular Devices in India, Overall, Company Share by Revenue ($ mn), 2005-2006 22
Table 17: Cardiovascular Devices, Interventional Cardiology in India, Company Share by Revenue ($ mn), 2005-2006 23
Table 18: Cardiovascular Devices, Peripheral Vascular Devices in India, Company Share by Revenue ($ mn), 2005-2006 24
Table 19: Cardiovascular Devices, Cardiac Rhythm Management in India, Company Share by Revenue ($ mn), 2005-2006 25
Table 20: Cardiovascular Devices, Cardiovascular Surgery in India, Company Share by Revenue ($ mn), 2005-2006 26
Table 21: Cardiovascular Devices, Cardiovascular Prosthetic Devices in India, Company Share by Revenue ($ mn), 2005-2006 27
Table 22: Cardiovascular Devices, Cardiovascular Monitoring and Diagnostic Devices in India, Company Share by Revenue ($ mn), 2005-2006 28
Table 23: Currency Conversion to USD at 2006 Constant Rate 30
For more information kindly visit: http://www.bharatbook.com/detail.asp?id=70920
Gail
This report is an essential source for key data relating to the India Cardiovascular Devices medical equipment market. The report offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information.
Scope of the Report
• This report provides detailed data on market size by volume and value.
• It gives key company share information for leading competitors in the market.
• Breaks down revenues by distribution channel.
• Provides forecasts of market values.
• All figures are based on rigorous research methodologies including in-depth primary and secondary research.
• Obtain the most up to date medical equipment market information available.
• Support sales activities by understanding your customers’ businesses better.
• Identify key growth market categories and segments.
• Develop your strategies on the basis of forecast market growth.
Table of Contents
CHAPTER 1 TABLE OF CONTENTS 2
1.01 List of tables 3
1.02 List of figures 5
CHAPTER 2 INTRODUCTION 6
2.01 What Is This Report About? 6
2.02 Market Definitions 6
Cardiovascular Devices 6
Interventional Cardiology 6
Peripheral Vascular Devices 6
Cardiac Rhythm Management 6
Cardiovascular Surgery 6
Cardiovascular Prosthetic Devices 7
Cardiovascular Monitoring and Diagnostic Devices 7
CHAPTER 3 CARDIOVASCULAR DEVICES OVERALL REVENUES 8
CHAPTER 4 CARDIOVASCULAR DEVICES CATEGORY REVENUES 11
CHAPTER 5 CARDIOVASCULAR DEVICES CATEGORY VOLUMES 15
CHAPTER 6 CARDIOVASCULAR DEVICES DISTRIBUTION SHARE 17
CHAPTER 7 CARDIOVASCULAR DEVICES COMPANY SHARE 22
CHAPTER 8 APPENDIX 29
8.01 Methodology 29
8.02 Currency Conversion 30
8.03 Contact Us 31
8.04 Disclaimer 31
List of Tables
Table 1: Cardiovascular Devices in India, Overall Revenues ($ mn), 2000-2011 8
Table 2: Cardiovascular Devices in India, Overall Revenues ($ mn), Historic, 2000-2006 9
Table 3: Cardiovascular Devices in India, Overall Revenues ($ mn), Forecast, 2006-2011 10
Table 4: Cardiovascular Devices in India, Category Revenues ($ mn), 2000-2011 12
Table 5: Cardiovascular Devices in India, Category Revenues ($ mn), Historic, 2000-2006 13
Table 6: Cardiovascular Devices in India, Category Revenues ($ mn), Forecast, 2006-2011 14
Table 7: Cardiovascular Devices in India, Category Volume (Units), 2000-2011 15
Table 8: Cardiovascular Devices in India, Category Volume (Units), Historic, 2000-2006 15
Table 9: Cardiovascular Devices in India, Category Volume (Units), Forecast, 2006-2011 16
Table 10: Cardiovascular Devices, Interventional Cardiology in India, Distribution by Revenue ($ mn), 2005-2006 17
Table 11: Cardiovascular Devices, Peripheral Vascular Devices in India, Distribution by Revenue ($ mn), 2005-2006 18
Table 12: Cardiovascular Devices, Cardiac Rhythm Management in India, Distribution by Revenue ($ mn), 2005-2006 19
Table 13: Cardiovascular Devices, Cardiovascular Surgery in India, Distribution by Revenue ($ mn), 2005-2006 19
Table 14: Cardiovascular Devices, Cardiovascular Prosthetic Devices in India, Distribution by Revenue ($ mn), 2005-2006 20
Table 15: Cardiovascular Devices, Cardiovascular Monitoring and Diagnostic Devices in India, Distribution by Revenue ($ mn), 2005-2006 21
Table 16: Cardiovascular Devices in India, Overall, Company Share by Revenue ($ mn), 2005-2006 22
Table 17: Cardiovascular Devices, Interventional Cardiology in India, Company Share by Revenue ($ mn), 2005-2006 23
Table 18: Cardiovascular Devices, Peripheral Vascular Devices in India, Company Share by Revenue ($ mn), 2005-2006 24
Table 19: Cardiovascular Devices, Cardiac Rhythm Management in India, Company Share by Revenue ($ mn), 2005-2006 25
Table 20: Cardiovascular Devices, Cardiovascular Surgery in India, Company Share by Revenue ($ mn), 2005-2006 26
Table 21: Cardiovascular Devices, Cardiovascular Prosthetic Devices in India, Company Share by Revenue ($ mn), 2005-2006 27
Table 22: Cardiovascular Devices, Cardiovascular Monitoring and Diagnostic Devices in India, Company Share by Revenue ($ mn), 2005-2006 28
Table 23: Currency Conversion to USD at 2006 Constant Rate 30
For more information kindly visit: http://www.bharatbook.com/detail.asp?id=70920
Gail
Singapore - Asia’s Premier Medical Hub
Saturday, May 2nd, 2009Singaporemedicine.com asked:
Singapore healthcare industry has achieved fame with a series of breakthrough medical procedures including the following events.
· In 1995, Singapore doctors carried out the world’s first successful peripheral blood stem cell transplant from an unrelated donor.
· In 2000, Singapore doctors performed Asia’s first unicompartmental arthroplasty.
· In 2001, Singapore doctors carried out Southeast Asia’s first heart transplant using an Electronic Heart Assist (Left Ventricular Assist Device) on a 36-year-old patient suffering from severely impaired heart function.
· In 2001, Singapore doctors successfully separated a pair of craniopagus, conjoined (joined at the head) twins from Nepal in a milestone operation that lasted more than 90 hours.
· The world’s first successful cord blood transplant from an unrelated donor on a patient with Thalassaemia Major, was performed in 2001.
· In 2002, Singapore doctors performed Southeast Asia’s first Adult Living Donor Liver Transplant.
· The revolutionary procedure of tooth-in-eye implant was performed successfully in 2004.
· Singapore doctors successfully separated conjoined twins at the stomach in 2005.
· In 2005, Singapore performed Asia’s first kidney cum bone marrow transplant.
In addition, Singapore has the most JCI-accredited hospitals in Asia. With internationally accredited hospitals, Singapore offers medical facilities that match the international healthcare standards at lower rates. This is one of the major reasons behind the booming medical tourism industry in Singapore. The following statistics will give you an idea of the medical travel scenario in Singapore.
· Every year, more than 300,000 healthcare visitors come to Singapore to seek medical treatment.
· In 2005, Singapore attracted 374,000 patient visitors.
· Asia’s medical tourism market will worth up to US$4 billion by 2012 and Singapore is focused to attract one million patients by year 2012.
Patients from Indonesia, Malaysia, the Middle East, Bangladesh, India, Australia and even from U.S. and U.K. are coming to Singapore in large numbers. So many patients from all corners of the world are flocking the hospitals in Singapore to seek specialist care in the areas of cardiology, gynaecology, orthopaedic surgery, oncology, otorhinolaryngology, urology, neurosurgery and opthalmology, along with general surgery and general medicine. There are a number of reasons behind this phenomenal increase of patients opting for medical travel to Singapore. Here, we are sharing just some of the key points with you that we think have been instrumental in making Singapore a hot spot in international healthcare scene.
· Specialized Centers - There are specialized centers of treatment including neurology, cardiology, ophthalmology, oncology and much more. These centers provide highest level of healthcare service that caters to patients coming from all across the globe for health screening as well as treatment.
· Experienced Professionals - There are wide pool of expert doctors to take care of the simple to most complex health problems. Besides, there are expert professionals working at the Singapore healthcare establishments to ensure optimum healthcare solution.
· Cutting Edge Technologies - Hospitals at Singapore have state of the art infrastructure to ensure top class treatment of the patients. The most advanced technologies puts Singapore at par with the US and UK hospitals.
· Advanced Treatment Procedures - Singapore is the biomedical research hub of Asia. There are extensive R&D facilities to explore new and more advanced medicines and treatment procedures.
· Peace of Mind - Singapore is a multilingual and multi-cultural city with truly cosmopolitan sprit. So, while you are in Singapore for medical reasons, you will never feel out of place. Your companions will be safe too as Singapore is well-known for its low-crime environment. Moreover, the organized travel and tourism industry is ready to take care of your travel and accommodation requirement in Singapore.
So, if you are suffering from any health problem or you want a proper health screening, come to Singapore and experience truly international quality healthcare facilities at unbelievable cost.
http://www.singaporemedicine.com
Contact Us
http://app.singaporemedicine.com/asp/fee/fee01a.asp
Lawrence
Singapore healthcare industry has achieved fame with a series of breakthrough medical procedures including the following events.
· In 1995, Singapore doctors carried out the world’s first successful peripheral blood stem cell transplant from an unrelated donor.
· In 2000, Singapore doctors performed Asia’s first unicompartmental arthroplasty.
· In 2001, Singapore doctors carried out Southeast Asia’s first heart transplant using an Electronic Heart Assist (Left Ventricular Assist Device) on a 36-year-old patient suffering from severely impaired heart function.
· In 2001, Singapore doctors successfully separated a pair of craniopagus, conjoined (joined at the head) twins from Nepal in a milestone operation that lasted more than 90 hours.
· The world’s first successful cord blood transplant from an unrelated donor on a patient with Thalassaemia Major, was performed in 2001.
· In 2002, Singapore doctors performed Southeast Asia’s first Adult Living Donor Liver Transplant.
· The revolutionary procedure of tooth-in-eye implant was performed successfully in 2004.
· Singapore doctors successfully separated conjoined twins at the stomach in 2005.
· In 2005, Singapore performed Asia’s first kidney cum bone marrow transplant.
In addition, Singapore has the most JCI-accredited hospitals in Asia. With internationally accredited hospitals, Singapore offers medical facilities that match the international healthcare standards at lower rates. This is one of the major reasons behind the booming medical tourism industry in Singapore. The following statistics will give you an idea of the medical travel scenario in Singapore.
· Every year, more than 300,000 healthcare visitors come to Singapore to seek medical treatment.
· In 2005, Singapore attracted 374,000 patient visitors.
· Asia’s medical tourism market will worth up to US$4 billion by 2012 and Singapore is focused to attract one million patients by year 2012.
Patients from Indonesia, Malaysia, the Middle East, Bangladesh, India, Australia and even from U.S. and U.K. are coming to Singapore in large numbers. So many patients from all corners of the world are flocking the hospitals in Singapore to seek specialist care in the areas of cardiology, gynaecology, orthopaedic surgery, oncology, otorhinolaryngology, urology, neurosurgery and opthalmology, along with general surgery and general medicine. There are a number of reasons behind this phenomenal increase of patients opting for medical travel to Singapore. Here, we are sharing just some of the key points with you that we think have been instrumental in making Singapore a hot spot in international healthcare scene.
· Specialized Centers - There are specialized centers of treatment including neurology, cardiology, ophthalmology, oncology and much more. These centers provide highest level of healthcare service that caters to patients coming from all across the globe for health screening as well as treatment.
· Experienced Professionals - There are wide pool of expert doctors to take care of the simple to most complex health problems. Besides, there are expert professionals working at the Singapore healthcare establishments to ensure optimum healthcare solution.
· Cutting Edge Technologies - Hospitals at Singapore have state of the art infrastructure to ensure top class treatment of the patients. The most advanced technologies puts Singapore at par with the US and UK hospitals.
· Advanced Treatment Procedures - Singapore is the biomedical research hub of Asia. There are extensive R&D facilities to explore new and more advanced medicines and treatment procedures.
· Peace of Mind - Singapore is a multilingual and multi-cultural city with truly cosmopolitan sprit. So, while you are in Singapore for medical reasons, you will never feel out of place. Your companions will be safe too as Singapore is well-known for its low-crime environment. Moreover, the organized travel and tourism industry is ready to take care of your travel and accommodation requirement in Singapore.
So, if you are suffering from any health problem or you want a proper health screening, come to Singapore and experience truly international quality healthcare facilities at unbelievable cost.
http://www.singaporemedicine.com
Contact Us
http://app.singaporemedicine.com/asp/fee/fee01a.asp
Lawrence